


Allecra Therapeutics Revenue
Biotechnology Research • Saint-Louis, Grand Est, France • 1-10 Employees
Allecra Therapeutics revenue & valuation
| Annual revenue | $3,500,000 |
| Revenue per employee | $700,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,200,000 |
| Total funding | $24,800,000 |
Key Contact at Allecra Therapeutics
Omar Lahlou
Director Regulatory Affairs
Company overview
| Headquarters | Saint-Louis, Grand Est, France |
| Phone number | +60719 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Antibiotic |
| Founded | 2013 |
| Employees | 1-10 |
| Socials |
About Allecra Therapeutics
Allecra Therapeutics, founded in 2013, is a private, clinical-stage biopharmaceutical company developing novel therapies to combat antibiotic resistance by overcoming emergent resistance mechanisms. Lead product candidate, cefepime/enmetazobactam, has shown superiority over standard of care in patients with complicated urinary tract infections (cUTIs) in a randomized, controlled, double-blind, global Phase 3 trial, and the Company is preparing submissions for marketing approval in the U.S. and EU based on these results. The Company has significant patent protection covering proprietary enmetazobactam in major territories. Allecra’s investors are: Forbion, Andera Partners, Delos Capital, Xeraya Capital, EMBL Ventures, and BioMedPartners. Allecra’s wholly owned French subsidiary is a beneficiary of financial support from Bpifrance and the Région Alsace.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Allecra Therapeutics Tech Stack
Discover the technologies and tools that power Allecra Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Advertising
CMS
UI frameworks
JavaScript libraries
JavaScript libraries
Programming languages
JavaScript frameworks
Authentication
UI frameworks
JavaScript libraries
Frequently asked questions
4.8
40,000 users



